4/A//SEC Filing
Hsu Frank J. 4/A
Accession 0001209191-20-044366
CIK 0001260990other
Filed
Jul 30, 8:00 PM ET
Accepted
Jul 31, 9:05 PM ET
Size
6.1 KB
Accession
0001209191-20-044366
Insider Transaction Report
Form 4/AAmended
Hsu Frank J.
Chief Medical Officer
Transactions
- Award
Stock Option
2019-08-26+150,000→ 150,000 totalExercise: $5.64Exp: 2029-08-26→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
- [F2]One-fourth (1/4th) of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments over the three-year period thereafter, subject to the Reporting Persons continued employment or service with the Issuer on each such date.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001786723
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 30, 8:00 PM ET
- Accepted
- Jul 31, 9:05 PM ET
- Size
- 6.1 KB